RNAC

Cartesian Therapeutics (RNAC)

About Cartesian Therapeutics (RNAC)

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.

Details

Daily high

$8.69

Daily low

$8.16

Price at open

$8.21

52 Week High

$15.57

52 Week Low

$5.60

Market cap

239.8M

Dividend yield

0.00%

Volume

172,223

Avg. volume

198,734

P/E ratio

-1.41

Cartesian Therapeutics News